George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Swing traders readying themselves for the start of a new year.
Keep digging and slinging mud DocD. I note that barely a day goes by without you wrongly accusing me of some ramping nonsense or other. The more I ignore, the more desperate your rants seem to become? Sitting in tight shorts at the end of the year, it must feel rather uncomfortable....
Very Excellent news.
Trade that, Prof & Co!
Thanks @TommyD_19 for that link. Isn't it notable that of the 910 spinouts that were enabled by UKRI funding, the UKRI chose to highlight just 3 of those in their 'Highlights' section of their report? 3, out of 910. Synairgen is one of those three.
"Spinout develops faster diagnoses and alternative treatments for lung infections Synairgen, a Southampton-based spinout company with 24 employees, is developing an inhaled interferon beta candidate for severe viral lung infections,
including asthma, COPD and COVID-19. Engaging with Southampton General Hospital, Synairgen’s COVID-19 trial reduced the waiting time of a point-of-care test used to recruit patients to within one hour, a dramatic reduction from one day, and had positive impacts on patient flow. Since its launch, Synairgen has raised more than £129 million to fund clinical trials, has increased its market capitalisation tenfold to £300 million, and has received £10 million through licensing. MRC-funded research has supported the discovery science underpinning inhaled interferon beta therapy
for nearly five decades, identifying many of the disease mechanisms involved."
As you said Patagucci, the need for the drug has certainly not gone away:
https://www.independent.co.uk/news/health/hospitals-flu-nhs-england-danger-b2460096.html
“The rise in winter viruses and staff sickness suggests that the pressure on health services is only going to continue to mount as we get deeper into winter."
Https://metro.co.uk/2023/11/30/denmark-sees-surge-white-lung-syndrome-demands-chinese-data-19906576/
It's interesting that Ethris signed a deal in 2017 with Aztra Zeneca (your fav BP Doc!). The deal was to last 5 years. Oddly, no mention of AZ anywhere about them wishing to extend that deal to develop MrNA tech with Ethris in the recent announcement below? In fact, not only has AZ seem to have vanished, but Ethris secured their own funding in early 2022 by raising$26.3 Million (€23.3 Million) in a Series B financing round led by Laureus Capital. They had to give a seat on the BOD to a n LC Exec as well. I guess they needed the cash with AZ gone? The proceeds of that funding were to advance the company’s lead programs ETH47 - a broad anti-viral immune modulator. Did AZ decide after 5 years to step away from the yet-to-be-clinically-tested Ethris drug for reasons better known to AZ...? It seem strange that they are no longer part of a collaboration? Perhaps it doesn't work as well as they hoped? Maybe a P1, and subsequent trials if there are some, will reveal more?
Let's try that again:
There's an excellent article here on what MrNA technology is good for, and more precisely what is is not. Well worth a read if you've not had a chance to delve into it much: https://www.science.org/content/blog-post/what-mrna-good-and-what-it-maybe-isn-t
It would be interesting to know what Tommy's thoughts are on this, seeing as he posted it.
There's an excellent article here on what MrNA technology is good for, and more precisely what is is not. Well worth a read if you've
It would be interesting to know what Tommy's thoughts are on this, seeing as he posted it.
I thought your dad worked in pharma XV?
"doom-laden nonsense"? As is usually the case, I expected you'd be triggered again DocD by simple factual media reporting. As for Earl's spurious nonsense, anyone with half a brain knows his game, your choice to engage, not a tactic I waste energy on. If throwing shade and your usually muckery in my direction gives you kicks and kudos, I won't rob you of that warm fuzzy feeling. You seem to need it.
Ref the news alignment, It is what it is - you can't alter reality.
As for the "I don't really know how t (p&d) works" comment, .... You really think anyone (other than your phony cohort of multiple personality disordered accounts) believes that? Maybe they can explain it to you. I'm crying, Lol....
I see only 60 trades (+/-)since 8am, none for huge money, in the multiple 100K's corporate sense. Perhaps you have access to more up to date data than I though.
xv refers to yesterday's paper that was highlighted by leading paediatricians, some on twitter/'x'. for those who missed it...."our findings suggest that covid-19 contributed to the 2022 surge of rsv cases in young children through the large buildup of covid-19-infected children and the potential long-term adverse effects of covid-19 on the immune and respiratory system.". the key words are "children" and "long term adverse effects". they now have evidence that kids who caught covid are likely to get hit harder by subsequent respiratory viruses, for life. add to that the news of china pneumonia circulating amongst a very young population, and the 1st human case in the uk of a strain of pig flu of as yet unknown transmission, and you have the perfect ****nal of news items shining a light on the likes of synairgen's work, which inevitably piques interest from new pi's and traders....
On Twitter (X) today, Krutika Kuppalli, MD, an infectious disease physician who is with the WHO's Health Emergencies Program, said it's possible that China could be seeing a surge in respiratory infections as other countries did their first winter after lockdowns lifted. She added that China has already reported a Mycoplasma pneumonia surge, but the current outbreaks could be anything. She also said respiratory syncytial virus, COVID-19, and flu could be contributing factors. "The point is we need information."
One to watch IMHO.
According to official sources, the person was not known to have worked with pigs. The source of the infection remains unknown and under investigation.
Https://www.gov.uk/government/news/ukhsa-detects-human-case-of-influenza-ah1n2v
"Trading in the first 13 weeks of the new financial year to October was “adversely impacted” by September’s record warm weather"
What, like the warm weather that spiked UK Cider sales in the same period? What a laughable statement.
As you'll know it was never ay different Ghia. Surprised that you are bothered, having sold out at 13p 6 months ago.
Back again for the 1st quartile action?
Wise words. I wish you well in your recovery Jonnyboy33.